MRK CEO on JPM webcast: Keytruda and Gardasil will continue strong growth in China even without inclusion in the NDRL (government reimbursement) list. Gardasil sales (worldwide) are constrained by production capacity, not demand.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”